It’s an appealing income play to consider MetLife Inc. (MET)

After finishing at $75.89 in the prior trading day, MetLife Inc. (NYSE: MET) closed at $76.92, up 1.36%. In other words, the price has increased by $+1.03 from its previous closing price. On the day, 3125570 shares were traded. MET stock price reached its highest trading level at $77.09 during the session, while it also had its lowest trading level at $76.02.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored

Ratios:

Our goal is to gain a better understanding of MET by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.16. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.70.

Upgrades & Downgrades

On June 23, 2022, Wolfe Research Upgraded its rating to Outperform which previously was Peer Perform and also upped its target price recommendation from $70 to $74.

On May 24, 2022, Citigroup started tracking the stock assigning a Buy rating and target price of $77.Citigroup initiated its Buy rating on May 24, 2022, with a $77 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 19 when Goulart Steven J sold 4,060 shares for $67.60 per share. The transaction valued at 274,456 led to the insider holds 55,299 shares of the business.

DEBEL MARLENE sold 4,060 shares of MET for $274,456 on Aug 19. The EVP & Chief Risk Officer now owns 55,299 shares after completing the transaction at $67.60 per share. On Feb 08, another insider, Goulart Steven J, who serves as the EVP & Chief Investment Officer of the company, sold 56,857 shares for $70.29 each. As a result, the insider received 3,996,376 and left with 215,376 shares of the company.

Valuation Measures:

As of this moment, MetLife’s Price-to-Earnings (P/E) ratio for their current fiscal year is 28.91, and their Forward P/E ratio for the next fiscal year is 9.26. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 425.09. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.81 while its Price-to-Book (P/B) ratio in mrq is 2.44.

Stock Price History:

Over the past 52 weeks, MET has reached a high of $76.17, while it has fallen to a 52-week low of $57.05. The 50-Day Moving Average of the stock is 68.37, while the 200-Day Moving Average is calculated to be 66.54.

Shares Statistics:

The stock has traded on average 4.40M shares per day over the past 3-months and 4.27M shares per day over the last 10 days, according to various share statistics. A total of 795.80M shares are outstanding, with a floating share count of 659.31M. Insiders hold about 0.10% of the company’s shares, while institutions hold 75.50% stake in the company. Shares short for MET as of Oct 13, 2022 were 8.92M with a Short Ratio of 11.10M, compared to 10.22M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.12% and a Short% of Float of 1.33%.

Dividends & Splits

In the trailing 12 months, MET’s forward annual dividend rate was 1.82, compared to 2.00 this year. Against a Trailing Annual Dividend Yield of 2.40%, it implies a Forward Annual Dividend Yield of 2.82%. The stock’s 5-year Average Dividend Yield is 3.58. The current Payout Ratio is 73.10% for MET, which recently paid a dividend on Dec 13, 2022 with an ex-dividend date of Nov 06, 2022. Stock splits for the company last occurred on Aug 06, 2017 when the company split stock in a 1122:1000 ratio.

Earnings Estimates

Its stock is currently analyzed by 16 different market analysts. On average, analysts expect EPS of $1.17 for the current quarter, with a high estimate of $1.67 and a low estimate of $0.74, while EPS last year was $2.39. The consensus estimate for the next quarter is $1.88, with high estimates of $2.09 and low estimates of $1.43.

Analysts are recommending an EPS of between $8.22 and $6.54 for the fiscal current year, implying an average EPS of $7.22. EPS for the following year is $8.36, with 17 analysts recommending between $8.8 and $7.98.

Revenue Estimates

7 analysts predict $20.58B in revenue for the current quarter. It ranges from a high estimate of $23.91B to a low estimate of $15.86B. As of the current estimate, MetLife Inc.’s year-ago sales were $16.28B, an estimated increase of 26.40% from the year-ago figure. For the next quarter, 7 analysts are estimating revenue of $17.37B, a decrease of -14.10% less than the figure of $26.40% in the same quarter last year. There is a high estimate of $18.51B for the next quarter, whereas the lowest estimate is $16.34B.

A total of 10 analysts have provided revenue estimates for MET’s current fiscal year. The highest revenue estimate was $77.44B, while the lowest revenue estimate was $69.39B, resulting in an average revenue estimate of $72.85B. In the same quarter a year ago, actual revenue was $70.24B, up 3.70% from the average estimate. Based on 10 analysts’ estimates, the company’s revenue will be $71.18B in the next fiscal year. The high estimate is $77.23B and the low estimate is $66.57B. The average revenue growth estimate for next year is down -2.30% from the average revenue estimate for this year.